LPCN icon

Lipocine

16 hedge funds and large institutions have $22.2M invested in Lipocine in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
JHIU
1
Janus Henderson Investors US
Colorado
$5.14M 842,813 +842,813 New
BBA
2
Baker Bros. Advisors
New York
$3.05M 500,000 +500,000 New
TCP
3
Tourbillon Capital Partners
New York
$2.75M 450,000 +450,000 New
SM
4
Sabby Management
Florida
$2.54M 416,700 +416,700 New
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$2.38M 390,000 +390,000 New
DMAM
6
Del Mar Asset Management
New York
$2.03M 333,333 +333,333 New
BC
7
Broadfin Capital
New York
$1.61M 264,532 +264,532 New
WC
8
Wexford Capital
Florida
$1.14M 186,000 +186,000 New
VM
9
VHCP Management
New York
$867K 142,100 +142,100 New
PCM
10
Prelude Capital Management
New York
$371K 60,806 +60,806 New
ISL
11
Ingalls & Snyder LLC
New York
$243K 39,885 +39,885 New
Millennium Management
12
Millennium Management
New York
$72K 11,806 +11,806 New
BIM
13
BlackRock Investment Management
Delaware
$9K 1,553 +1,553 New
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$6K 1,000 +1,000 New
TRCT
15
Tower Research Capital (TRC)
New York
$5K 868 +868 New
Morgan Stanley
16
Morgan Stanley
New York
$0 22 +22 New